Context Economic evaluations are far less frequently reported for medical devices than for drugs. In addition, little is known about the quality of existing economic evaluations, particularly for inno
Supplementary Table 1. Patient baseline characteristics between Type A and Type B groups. Supplementary Table 2. Difference in costs between hypertensive and non-hypertensive patients.
